Fig. 3.
Profile of adverse events.
Severity of adverse events was assessed using common toxicity criteria for the entire duration of therapy (n = 25 patients).
Profile of adverse events.
Severity of adverse events was assessed using common toxicity criteria for the entire duration of therapy (n = 25 patients).
